{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:28:24Z","timestamp":1769833704793,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,6,28]],"date-time":"2009-06-28T00:00:00Z","timestamp":1246147200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s00595-008-3909-1","type":"journal-article","created":{"date-parts":[[2009,6,27]],"date-time":"2009-06-27T01:18:34Z","timestamp":1246065514000},"page":"598-602","source":"Crossref","is-referenced-by-count":8,"title":["Gefitinib and a ventriculo-peritoneal shunt to manage carcinomatous meningitis from non-small-cell lung cancer: Report of two cases"],"prefix":"10.1007","volume":"39","author":[{"given":"Tetsuya","family":"So","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Chikaishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiro","family":"Nose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Sugio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosei","family":"Yasumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,6,28]]},"reference":[{"key":"3909_CR1","first-page":"2333","volume-title":"Carcinomatous meningitis. Cancer principles and practice of oncology","author":"D.A. Larson","year":"2005","unstructured":"Larson DA, Rubenstein JL, Mcdermott MW. Carcinomatous meningitis. Cancer principles and practice of oncology. 7th ed. Philadelphia: Lippincott, Williams and Wilkins; 2005. p. 2333\u20132335.","edition":"7th ed."},{"key":"3909_CR2","doi-asserted-by":"crossref","first-page":"879","DOI":"10.2482\/haigan.36.879","volume":"36","author":"K. Kimura","year":"1996","unstructured":"Kimura K, Sakai H, Sumimoto H, Hibino S, Goto I, Yoneda S, et al. Leptomeningeal carcinomatosis in patients with lung cancer. Jpn J Lung Cancer 1996;36:879\u2013883.","journal-title":"Jpn J Lung Cancer"},{"key":"3909_CR3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/ctrv.1999.0119","volume":"25","author":"S.A. Grossman","year":"1999","unstructured":"Grossman SA, Krabak MJ. Leptomeningeal carcinomatosis. Cancer Treat Rev 1999;25:103\u2013119.","journal-title":"Cancer Treat Rev"},{"key":"3909_CR4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1200\/JCO.1993.11.3.561","volume":"11","author":"S.A. Grossman","year":"1993","unstructured":"Grossman SA, Finkelstein DM, Ruckdeschel JC, Trump DL, Moynihan T, Ettinger DS. Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. J Clin Oncol 1993;11:561\u2013569.","journal-title":"J Clin Oncol"},{"key":"3909_CR5","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7","volume":"49","author":"W.R. Wasserstrom","year":"1982","unstructured":"Wasserstrom WR, Glass JP, Posner JB. Diagnosis and treatment of leptomeningeal metastases from solid tumors. Experience with 90 patients. Cancer 1982;49:759\u2013772.","journal-title":"Cancer"},{"key":"3909_CR6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00001622-200111000-00012","volume":"13","author":"C.L. Arteaga","year":"2001","unstructured":"Arteaga CL, Johnson DH. Tyrosine kinase inhibitors-ZD1839 (Iressa). Curr Opin Oncol 2001;13:491\u2013498.","journal-title":"Curr Opin Oncol"},{"key":"3909_CR7","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1007\/s00595-006-3453-9","volume":"37","author":"T. Hanagiri","year":"2007","unstructured":"Hanagiri T, Sugio K, Uramoto H, So T, Ichiki Y, Sugaya M, et al. Gender difference as a prognostic factor in patients undergoing resection of non-small cell lung cancer. Surg Today 2007;37:546\u2013551.","journal-title":"Surg Today"},{"key":"3909_CR8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.lungcan.2003.12.014","volume":"44","author":"P.A. J\u00e4nne","year":"2004","unstructured":"J\u00e4nne PA, Gurubhagavatula S, Yeap BY, Lucca J, Ostler P, Skarin AT, et al. Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, \u201cIressa\u201d) on an expanded access study. Lung Cancer 2004;44:221\u2013230.","journal-title":"Lung Cancer"},{"key":"3909_CR9","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1001\/jama.290.16.2149","volume":"290","author":"M.G. Kris","year":"2003","unstructured":"Kris MG, Natale RB, Herbst RS, Lynch TJ Jr, Prager D, Belani CP, et al. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial. JAMA 2003;290:2149\u20132158.","journal-title":"JAMA"},{"key":"3909_CR10","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1200\/JCO.2004.08.158","volume":"22","author":"V.A. Miller","year":"2004","unstructured":"Miller VA, Kris MG, Shah N, Patel J, Azzoli C, Gomez J, et al. Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer. J Clin Oncol 2004;22:1103\u20131109.","journal-title":"J Clin Oncol"},{"key":"3909_CR11","first-page":"61","volume":"81","author":"J.G. Paez","year":"2004","unstructured":"Paez JG, J\u00e4nne PA, Lee JC, Tracy S, Greulich H, Gabriel S, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004;81:61\u201369.","journal-title":"Science"},{"key":"3909_CR12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.lungcan.2005.05.022","volume":"50","author":"M.K. Kim","year":"2005","unstructured":"Kim MK, Lee KH, Lee JK, Choi JH, Hyun MS. Gefitinib is also active for carcinomatous meningitis in NSCLC. Lung Cancer 2005;50:265\u2013269.","journal-title":"Lung Cancer"},{"key":"3909_CR13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.lungcan.2006.05.016","volume":"53","author":"N. Hashimoto","year":"2006","unstructured":"Hashimoto N, Imaizumi K, Honda T, Kawabe T, Nagasaka T, Shimokata K, et al. Successful re-treatment with gefitinib for carcinomatous meningitis as disease recurrence of non-small-cell lung cancer. Lung Cancer 2006;53:387\u2013390.","journal-title":"Lung Cancer"},{"key":"3909_CR14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10147-005-0558-x","volume":"11","author":"M. Sakai","year":"2006","unstructured":"Sakai M, Ishikawa S, Ito H, Ozawa Y, Yamamoto T, Onizuka M, et al. Carcinomatous meningitis from non-small-cell lung cancer responding to gefitinib. Int J Clin Oncol 2006;11:243\u2013245.","journal-title":"Int J Clin Oncol"},{"key":"3909_CR15","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1378\/chest.111.6.1718","volume":"111","author":"C.F. Mountain","year":"1997","unstructured":"Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997;111:1718\u20131723.","journal-title":"Chest"},{"key":"3909_CR16","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1200\/JCO.2003.12.122","volume":"21","author":"M.P. Mehta","year":"2003","unstructured":"Mehta MP, Rodrigus P, Terhaard CH, Rao A, Suh J, Roa W, et al. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol 2003;21:2529\u20132536.","journal-title":"J Clin Oncol"},{"key":"3909_CR17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.bjc.6601478","volume":"89","author":"A. Katz","year":"2003","unstructured":"Katz A, Zalewski P. Quality-of-life benefits and evidence of antitumor activity for patients with brain metastases treated with gefitinib. Br J Cancer 2003;89:15\u201318.","journal-title":"Br J Cancer"},{"key":"3909_CR18","first-page":"795","volume":"44","author":"J. Sudo","year":"2006","unstructured":"Sudo J, Honmura Y, Kurimoto F, Komagata H, Sakai H, Yoneda S. Meningeal carcinomatosis in patients with lung cancer. J Jpn Assoc Chest Surg 2006;44:795\u2013799.","journal-title":"J Jpn Assoc Chest Surg"},{"key":"3909_CR19","first-page":"129","volume":"47","author":"P. Chinnaiyan","year":"2005","unstructured":"Chinnaiyan P, Huang S, Vallabhaneni G, Armstrong E, Varambally S, Tomlins SA, et al. Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva). Cancer Res 2005;47:129\u2013138.","journal-title":"Cancer Res"},{"key":"3909_CR20","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1212\/01.WNL.0000160396.69050.DC","volume":"64","author":"A.M. Omuro","year":"2005","unstructured":"Omuro AM, Lallana EC, Bilsky MH, DeAngelis LM. Ventriculoperitoneal shunt in patients with leptomeningeal metastasis. Neurology 2005;64:1625\u20131627.","journal-title":"Neurology"},{"key":"3909_CR21","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1445-2197.1976.tb03251.x","volume":"46","author":"P. King","year":"1976","unstructured":"King P. The peritoneal complications of ventriculo-peritoneal shunts. Aust N Z J Surg 1976;46:372\u2013377.","journal-title":"Aust N Z J Surg"},{"key":"3909_CR22","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/1097-0142(19810815)48:4<1033::AID-CNCR2820480430>3.0.CO;2-R","volume":"48","author":"I.C. Haimovic","year":"1981","unstructured":"Haimovic IC, Sharer L, Hyman RA, Beresford HR. Metastasis of intracranial germinoma through a ventriculoperitoneal shunt. Cancer 1981;48:1033\u20131036.","journal-title":"Cancer"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-008-3909-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00595-008-3909-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-008-3909-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T14:01:00Z","timestamp":1559138460000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00595-008-3909-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6,28]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["3909"],"URL":"https:\/\/doi.org\/10.1007\/s00595-008-3909-1","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6,28]]}}}